Ambiguities in the preclinical quality assessment of microparticulate vaccines.

Ambiguities in the preclinical quality assessment of microparticulate vaccines.

Item
http://www.wikidata.org/entity/Q33887559
Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.Microparticles as vaccine adjuvants and delivery systems.Nanoparticles and microparticles as vaccine-delivery systems.Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy.Poly(lactic acid-glycolic acid) nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis.Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles.Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.
P2860

Ambiguities in the preclinical quality assessment of microparticulate vaccines.

Item
http://www.wikidata.org/entity/Q33887559
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@ast
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
type
label
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@ast
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
prefLabel
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@ast
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Ambiguities in the preclinical quality assessment of microparticulate vaccines.
@en
P2093
P304
P31
P356
10.1016/S0167-7799(00)01437-2
P433
P478
P577
P698